Measuring blood pressure and treating hypertension in (Frail) Older people

Journal of the American Geriatrics Society

Volumn 47, Issue 3, 1999, Pages 373-374

  Cushman, William C ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; DIURETIC AGENT; NITRENDIPINE;

ADULT; AGED; AGING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; EDITORIAL; ELDERLY CARE; HUMAN; HYPERTENSION; NURSING HOME; PATIENT COMPLIANCE;

EID: 0032935387     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb03007.x     Document Type: Editorial

References (19)

1. Auseon A, Ooi WL, Hossain M, Lipsitz LA,. Blood pressure behavior in the nursing home: Implications for diagnosis and treatment of hypertension. J Am Geriatr Soc 1999; 47: 0000-0000.
2. Kannel WB, Dawber TR, McGee DL,. Perspectives on systolic hypertension: The Framingham study. Circulation 1980; 61: 1179-1182.
3. Dyer AR,. An analysis of the relationship of systolic blood pressure, serum cholesterol, and smoking to 14-year mortality in the Chicago Peoples Gas Company Study. II. Coronary and cardiovascular-renal mortality in two competing risk models. J Chron Dis 1975; 28: 571-578.
4. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413-2446.
5. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
6. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: Principal results. BMJ 1992; 304: 405-412.
7. Dahlof B, Lindholm LH, Hansson L, et at. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
8. Staessen JA, Fagard R, Thijs L, et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764.
9. Black HR, Elliott WJ, Neaton JD, et al., Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials 1998; 19: 370-390.
10. SHEP Cooperative Research Group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21: 335-343.
11. Kostis JB, Davis BR, Cutler JA et al., for the SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997; 278: 212-216.
12. Materson BJ, Reda DJ, Cushman WC et al., for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-921.
13. Materson BJ, Reda DJ, Cushman WC, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs Single-Drug Therapy of Hypertension Study: Revised figures and new data. Am J Hypertens 1995; 8: 189-192.
14. VA Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972; 45: 991-1004.
15. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex and age. JAMA 1979; 242: 2572-2577.
16. The Management Committee, Australian National Blood Pressure Study. Treatment of mild hypertension in the elderly. Med J Aust 1981; 2: 398-402.
17. Amery A, Birkenhager W, Brixco P, et al., Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; 1: 1349-1354.
18. Messerli FH, Grossman E, Goldbourt U,. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 279: 1903-1907.
19. Davis BR, Cutler JA, Gordon DJ et al., for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens 1996; 9: 342-360.